Lv66
1830 积分 2024-03-25 加入
Tertiary lymphoid structures in cancer and beyond
2天前
已完结
Rapid Generation of hPSC‐Derived High Endothelial Venule Organoids with In Vivo Ectopic Lymphoid Tissue Capabilities
2天前
已完结
LTβR Agonism Promotes Anti-Tumor Immune Responses via Modulation of the Tumor Microenvironment
6天前
已完结
Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: a single-arm, phase 2 trial
9天前
已完结
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma
9天前
已完结
QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion
1个月前
已完结
Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity
4个月前
已完结
Potency of a Scalable Nanoparticulate Subunit Vaccine
6个月前
已完结
Nanovaccines Fostering Tertiary Lymphoid Structure to Attack Mimicry Nasopharyngeal Carcinoma
6个月前
已完结
FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells
6个月前
已完结
皖公网安备34019202002308
